Anjalee Khemlani

Medical devices, or the medtech sector, are not immune from the reciprocal tariffs announced by Trump yesterday.

The FDA was supposed to make a final decision about approval of Novavax's COVID-19 vaccine this week, but that deadline has passed with no clarity on when the decision will move forward again.

Some of the country's largest drugmakers could be impacted by President Donald Trump's reciprocal tariffs, announced on Wednesday from the Rose Garden.

Some of the country's largest drugmakers could be impacted by President Donald Trump's reciprocal tariffs, announced on Wednesday from the Rose Garden.

J&J's attempt to finally settle the ongoing talc lawsuits hit a new speed bump Tuesday when a bankruptcy judge denied the company's attempt to resolve the litigation.

J&J's attempt to finally settle the ongoing talc lawsuits hit a new speed bump Tuesday when a bankruptcy judge denied the company's attempt to resolve the litigation.

The resignation of one of the FDA's top officials, Peter Marks, is worrying Wall Street as they await a replacement.

Cigna (CI) CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the US is the only country among developed nations where insurance coverage is being debated.

Companies looking to compete in the GLP-1 market are adding value to the R&D spend across the pharma sector.

Egg prices are on the decline, but a spring migration could upend that. Former FDA Scott Gottlieb has ideas on how to prevent another spike in pricing.